Furthermore, we demonstrate that the expression of PDK1, PHD3, and HIF-1α proteins in NB tumor samples can be used in immunohistochemistry to evaluate the hypoxic status of NB tumors, and could, therefore, be successfully used as a relevant tool to stratify high-risk patients. The gene discussed is HIF1A; the disease is neuroblastoma.